Articles amb requisits d'accés públic - Abigail T. BermanMés informació
No estan disponibles en cap lloc: 2
A prospective study of proton beam reirradiation for esophageal cancer
A Fernandes, AT Berman, R Mick, S Both, K Lelionis, JN Lukens, ...
International Journal of Radiation Oncology* Biology* Physics 95 (1), 483-487, 2016
Requisits: US National Institutes of Health
Grade inflation in medical student radiation oncology clerkships: missed opportunities for feedback?
S Grover, S Swisher-McClure, S Sosnowicz, J Li, N Mitra, AT Berman, ...
International Journal of Radiation Oncology* Biology* Physics 92 (4), 740-744, 2015
Requisits: US National Institutes of Health
Disponibles en algun lloc: 23
Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non–small cell lung cancer
C Aggarwal, JC Thompson, TA Black, SI Katz, R Fan, SS Yee, AL Chien, ...
JAMA oncology 5 (2), 173-180, 2019
Requisits: US National Institutes of Health
Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer
A Kalbasi, J Li, AT Berman, S Swisher-McClure, M Smaldone, RG Uzzo, ...
JAMA oncology 1 (7), 897-906, 2015
Requisits: US National Institutes of Health
Phase 1 trial of Pembrolizumab administered concurrently with Chemoradiotherapy for locally advanced non–small cell lung cancer: a nonrandomized controlled trial
SK Jabbour, AT Berman, RH Decker, Y Lin, SJ Feigenberg, SN Gettinger, ...
JAMA oncology 6 (6), 848-855, 2020
Requisits: US National Institutes of Health
Baseline plasma tumor mutation burden predicts response to pembrolizumab-based therapy in patients with metastatic non–small cell lung cancer
C Aggarwal, JC Thompson, AL Chien, KJ Quinn, WT Hwang, TA Black, ...
Clinical Cancer Research 26 (10), 2354-2361, 2020
Requisits: US National Institutes of Health, LUNGevity Foundation, USA
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
A Maity, R Mick, AC Huang, SM George, MD Farwell, JN Lukens, ...
British journal of cancer 119 (10), 1200-1207, 2018
Requisits: US National Institutes of Health
Circulating tumor cells are associated with recurrent disease in patients with early-stage non–small cell lung cancer treated with stereotactic body radiotherapy
MA Frick, SJ Feigenberg, SR Jean-Baptiste, LA Aguarin, A Mendes, ...
Clinical Cancer Research 26 (10), 2372-2380, 2020
Requisits: US National Institutes of Health
Empiric Radiotherapy for Lung Cancer Collaborative Group multi-institutional evidence-based guidelines for the use of empiric stereotactic body radiation therapy for non-small …
AT Berman, SK Jabbour, A Vachani, C Robinson, JI Choi, P Mohindra, ...
Translational lung cancer research 8 (1), 5, 2019
Requisits: US National Institutes of Health
Early detection of recurrence in patients with locally advanced non–small-cell lung cancer via circulating tumor cell analysis
C Chinniah, L Aguarin, P Cheng, C Decesaris, A Cutillo, AT Berman, ...
Clinical lung cancer 20 (5), 384-390. e2, 2019
Requisits: US National Institutes of Health
Outcomes in patients with non–small-cell lung cancer with brain metastases treated with pembrolizumab-based therapy
L Sun, CW Davis, WT Hwang, S Jeffries, LF Sulyok, ME Marmarelis, ...
Clinical Lung Cancer 22 (1), 58-66. e3, 2021
Requisits: US National Institutes of Health
Focusing on the “person” in personalized medicine: the future of patient-centered care in radiation oncology
AT Berman, SA Rosenthal, D Moghanaki, KD Woodhouse, B Movsas, ...
Journal of the American College of Radiology 13 (12), 1571-1578, 2016
Requisits: Patient-Centered Outcomes Research Institute
Effect of prophylactic cranial irradiation on overall survival in metastatic small-cell lung cancer: a propensity score-matched analysis
S Sharma, MT McMillan, A Doucette, RB Cohen, A Berman, W Levin, ...
Clinical lung cancer 19 (3), 260-269. e3, 2018
Requisits: US National Institutes of Health
LGM2605 reduces space radiation-induced NLRP3 inflammasome activation and damage in in vitro lung vascular networks
S Chatterjee, RA Pietrofesa, K Park, JQ Tao, A Carabe-Fernandez, ...
International journal of molecular sciences 20 (1), 176, 2019
Requisits: US National Institutes of Health, US National Aeronautics and Space …
Circulating tumor cell assessment in presumed early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy: a prospective pilot study
MA Frick, GD Kao, L Aguarin, C Chinniah, S Swisher-McClure, ...
International Journal of Radiation Oncology* Biology* Physics 102 (3), 536-542, 2018
Requisits: US National Institutes of Health
Synthetic secoisolariciresinol diglucoside (LGM2605) protects human lung in an ex vivo model of proton radiation damage
A Velalopoulou, S Chatterjee, RA Pietrofesa, C Koziol-White, ...
International journal of molecular sciences 18 (12), 2525, 2017
Requisits: US National Institutes of Health
Combining natural and artificial intelligence for robust automatic anatomy segmentation: Application in neck and thorax auto‐contouring
JK Udupa, T Liu, C Jin, L Zhao, D Odhner, Y Tong, V Agrawal, ...
Medical physics 49 (11), 7118-7149, 2022
Requisits: US National Institutes of Health
Introductory radiation oncology curriculum: Report of a national needs assessment and multi-institutional pilot implementation
JR Gunther, RB Jimenez, RL Yechieli, A Parekh, AT Berman, ...
International Journal of Radiation Oncology* Biology* Physics 101 (5), 1029-1038, 2018
Requisits: US National Institutes of Health
Multiblock discriminant analysis of integrative 18F-FDG-PET/CT radiomics for predicting circulating tumor cells in early-stage non-small cell lung cancer treated with …
SH Lee, GD Kao, SJ Feigenberg, JF Dorsey, MA Frick, S Jean-Baptiste, ...
International Journal of Radiation Oncology* Biology* Physics 110 (5), 1451-1465, 2021
Requisits: US National Institutes of Health
Early changes in physical activity and quality of life with thoracic radiation therapy in breast cancer, lung cancer, and lymphoma
S Krishnan, HK Narayan, G Freedman, JP Plastaras, A Maity, B Demissei, ...
International Journal of Radiation Oncology* Biology* Physics 109 (4), 946-952, 2021
Requisits: US National Institutes of Health
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic